Funds for R&D in drug discovery and manufacturing :PIB
An outlay of Rs. 1,500 crore has been approved for strengthening/ up-gradation of these NIPERs for the period 2021-22 to 2025-26.
An outlay of Rs. 1,500 crore has been approved for strengthening/ up-gradation of these NIPERs for the period 2021-22 to 2025-26.
Better serving global partners and advancing healthcare innovation
Abbott has recently received the US Food and Drug Administration nod to use its DBS device for treatment-resistant depression
The funds raised in the seed round will be used for research and development of Shri Chyawan Ayurved Product
PM congratulates citizens on crossing the 200 crore milestone of Covid vaccination drive
Manish led SeQuent since 2014 and played a major role in transforming the company
ExoBrite antibody conjugates are validated and optimized for bright and specific detection of exosome markers
Strand Life Sciences has sequenced a total of 12800 samples from July, 2021 to June, 2022, and identified more than a 100 lineages circulating in Bengaluru
George Svokos joins Avet after serving as a strategic business advisor to numerous global healthcare companies
Subscribe To Our Newsletter & Stay Updated